Retained products of conception: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{SI}} {{CMG}} ==Overview== Retained products of conception complicate nearly 1% of all pregnancies. It occurs with greater frequency after termination of pregnancy ...") |
|||
| Line 24: | Line 24: | ||
Image: | Image: | ||
Retained products of conception CT 004.jpg | |||
Image: | Image: | ||
Retained products of conception CT 005.jpg | |||
</gallery> | </gallery> | ||
Revision as of 15:18, 1 August 2012
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Retained products of conception complicate nearly 1% of all pregnancies. It occurs with greater frequency after termination of pregnancy than after vaginal or cesarean delivery.
Differentiating retained products of conception from other diseases
- Differentiation of these entities is important because retained products of conception is treated conservatively or with curettage while gestational trophoblastic disease may require chemotherapy.
- ß-human chorionic gonadotropin remains elevated in patients with gestational trophoblastic disease but falls to an undetectable level over 2–3 weeks in patients with retained products of conception.
Diagnosis
- Common symptoms include vaginal bleeding and abdominal or pelvic pain, similar to patients with gestational trophoblastic disease.
Patient #1: US and CT images demonstrate retained products of conception
